Disease activity and pregnancy outcomes after different natalizumab exposure patterns during pregnancy in women with MS - Results from the German Multiple Sclerosis and Pregnancy Registry. DGN-Kongress Berlin 2021 (Poster) - Litvin, N; Thiel, S; Haben, S
et al.